Valneva to present on its single-shot chikungunya vaccine candidate, host symposium at nectm8

Saint - herblain ( france), june 7 , 20 22 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, announced today it will present on its single-shot chikungunya vaccine candidate vla1553 on june 9, 2022 at the 8th northern european conference on travel medicine (nectm8) in rotterdam.

VALN Ratings Summary

VALN Quant Ranking